for the left side, and was successfully treated in the same manner as for the left-sided lesion. Mild chest pain was the only adverse event. The metastasis of bilateral lung parenchyma rapidly exacerbated six months after the treatment of left-sided pneumohemothorax, and the patient died of the disease. Intrapleural administration of a taxane preparation for pleural effusion due to malignant tumours has been reported [1] [2] [3] [4] . Perng demonstrated the efficacy of this procedure in 14 patients with non-small-cell lung cancer (NSCLC) [1] . After a four-week observation period, the overall response rate of pleural effusion was 92.9%, with a complete response rate of 28.6%. Docetaxel was also beneficial for controlling malignant pleural effusion in NSCLC and breast cancer patients [2] . Adverse events associated with the intrapleural administration of a taxane preparation include chest and/or shoulder pain, fever, nausea, and an increase in transaminases. Renal failure and infection are relatively rare, but occasionally very severe [1, 2] . Our patient is the first case of angiosarcoma-related pneumohemothorax treated with the intrapleural administration of a taxane preparation. The prognosis of angiosarcoma is very poor, particularly with pneumohemothorax. The intrapleural administration of a taxane preparation is not a radical cure, but may be used as palliative care. Our patient spent his last few months with his family at home because the pleural effusion was controlled by the intrapleural administration of paclitaxel. It is difficult to estimate the impact of intrapleural administration of paclitaxel on prognosis. However, the intrapleural administration of a taxane preparation is an option for palliative care for angiosarcoma patients with pneumohemothorax. Candidal vulvitis: a possible trigger for lichen striatus
A 33-year-old woman presented with a pruritic rash on her left leg. Dermatological examination revealed an erythematous, mildly oedematous vulva and small, flat, erythematous, blaschkoid papules extending from the left inguinal fold to the medial side of the left knee ( figure 1A, B) . Approximately one month prior, she had visited a gynaecology clinic due to an itchy vulva, and received a corticosteroid cream for suspected allergic vulvitis. The pruritus persisted after one week of treatment, and ornidazole at 500 mg/d, ciprofloxacin at 1 g/d, and a daily pessary combining 500 mg of metronidazole and 100 mg of miconazole nitrate were prescribed for "vulvovaginitis". Her symptoms slightly improved, however, a blaschkoid rash appeared three weeks later on her left leg. At the time of her first visit to our clinic, the patient's complete blood count, erythrocyte sedimentation rate (ESR), and CRP were within normal range. Skin swabs were taken in order to identify a possible pathogen. cultures were negative, but the potassium hydroxide (KOH) test revealed pseudohyphae and budding yeast cells, consistent with candidal infection. Skin biopsy of the blaschkoid papules was performed. Clotrimazole cream for inguinal intertrigo and pimecrolimus cream for the blaschkolinear inflammation, both twice daily, were started, and remission of vulvitis was observed after ten days. Skin biopsy showed focal parakeratosis, irregular acanthosis, and liquefaction degeneration in the epidermal basal layer and a dermal, band-like lymphocytic infiltration, suggestive of lichen striatus (LS) ( figure 1D ). The patient continued with daily application of pimecrolimus cream. Twelve weeks later, the blaschkolinear inflammation had nearly completely regressed, except for a group of papules near the inguinal fold ( figure 1C) . LS is an uncommon, acquired, self-limiting dermatosis of unknown aetiology, which is frequently observed in children and typically manifests as unilateral, erythematous, asymptomatic, flat papules and/or plaques along Blaschko's lines. Some authors differentiate LS from similar lesions observed in adults by classifying the latter as blaschkitis, whereas others consider such a classification to be unnecessary [1] . Although viral infections, trauma, vaccines, and various drugs have been reported as possible triggering factors, the exact aetiopathogenesis of this condition remains unclear [2] . Clinical and histopathological features of LS suggest a T-lymphocyte-mediated immune reaction 
Eosinophilia and systemic symptoms with transient ageusia: a drug reaction caused by zonisamide
Drug-induced taste disorders (DITDs) represent a side effect of drugs and usually occur without other symptoms. To date, no drug eruption has ever been reported in association with DITD. We report herein a case of zonisamide-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with transient but severe ageusia.
A 50-year-old man with epilepsy had been treated with sodium valproate, phenytoin, phenobarbital, and diazepam for six years. Three months after the additional administration of zonisamide, he developed a skin rash. We suspected drug eruption and administered systemic prednisolone (PSL) at 15 mg/d for a week (Day 1). The rash exacerbated, with exudative erythema covering 60% of the body surface, facial oedema, and lymphadenopathy, accompanied by fever (39 • C) ( figure 1A) . We clinically suspected DRESS and the patient was admitted to our hospital. Blood tests revealed a leukocyte count of 28,300/mm 3 (eosinophils: 17.5%; lymphocytes: 32.5%; neutrophils: 16.0%; atypical lymphocytes: 14.5%). Liver enzymes were increased, but renal function was normal. A skin biopsy from the rash showed a superficial perivascular dermatitis without individual cell keratinization or interface changes. The final diagnosis of DRESS was made by using the scoring system for DRESS [1] (table S1) .
Zonisamide was changed to levetiracetam and increased the systemic PSL dose to 45 mg/d. The rash improved and the dose of PSL was tapered ( figure 1D ). The patient had three peaks of fever ( figure 1D ). Human herpes virus 6 (HHV6) IgG titre was increased 10-fold (Day 7) to 2,560-fold (Day 22), suggesting HHV6 reactivation. At the first febrile peak, . B) The tongue is reddish and lacks a coating on Day 11, after the onset of DIHS. C) The tongue appears normal, with tongue coating apparent three months after the patient was discharged (the patient's sense of taste had recovered by this time). D) Clinical course of the patient. At the first febrile peak, the patient felt intraoral pain which hampered eating. After this peak, mouth pain was reduced, but a taste disorder developed. The patient was aware of ageusia on Day 11. The patient was followed in our outpatient clinic, and his ability to taste salty foods recovered on Day 42, followed by his ability to taste sweetness, and then sour and bitter foods. Two months after the onset of DRESS, his ability to recognise all four types of taste had recovered. The absolute numbers of eosinophils (EOS), atypical lymphocytes (A-LYMP), and platelets (PLT) are shown chronologically.
the patient felt an intraoral burning sensation which was severe enough to hamper eating. He was only able to drink water. After the first febrile peak, mouth pain decreased, but he noticed ageusia. At that time, his tongue showed redness and a lack of coating ( figure 1B) . The Saxon test and wholemouth gustatory tests were performed by otolaryngologists, and brain magnetic resonance imaging (MRI) was carried out. All tests were negative except for the Saxon test with a result (1.85 g/2 min; normal >2 g/2 min) indicating a slightly dry mouth. Serum iron, zinc, and copper concentrations were within normal limits. Vitamin B12 level was 2,160 pg/mL (normal: 233-914 pg/dL). The patient's ability to taste salt recovered 29 days after the onset of ageusia and nine days later, his ability to taste sweetness also recovered.
